Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Gross Profit | N/A | 18,416 | 14,412 | 14,412 |
| Operating Expenses | 0 | 5,760 | 4,839 | 4,839 |
| Operating Income | N/A | -5,760 | -4,839 | -4,839 |
| Pre-tax Income | 0 | -5,760 | -4,839 | -4,839 |
| Net Income Continuous | N/A | -5,760 | -4,839 | -4,839 |
| Net Income | $N/A | $-5,760 | $-4,839 | $-4,839 |
| EBITDA(a) | $N/A | $-3,771 | $-3,526 | $-3,526 |